| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Nov 26, 2024 | Lineage Cell Therapeutics, Inc. | CFO | Buy | 90.0 | +15,000 | 142.86% | ✗ | $8.9K |
| Aug 16, 2024 | Aug 19, 2024 | Lineage Cell Therapeutics, Inc. | CFO | Buy | 90.0 | +10,500 | 100.00% | ✗ | $9.3K |